Comparing epidemiological and clinical data from RPS patients documented in a German cancer registry to a cohort from TARPSWG reference centres.

Autor: Neemann F; Department of Surgery, Sarcoma Unit, University Medical Center Mannheim (UMM) and Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany., Jansen L; German Cancer Research Center (DKFZ), Epidemiological Cancer Registry Baden-Württemberg, Heidelberg, Germany., Hermann S; German Cancer Research Center (DKFZ), Epidemiological Cancer Registry Baden-Württemberg, Heidelberg, Germany., Silcher C; Department of Surgery, Sarcoma Unit, University Medical Center Mannheim (UMM) and Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany., Hettler M; Department of Surgery, Sarcoma Unit, University Medical Center Mannheim (UMM) and Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany., Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, University Medical Centre Mannheim (UMM) and Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Callegaro D; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gronchi A; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fiore M; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Miceli R; Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Biostatistics for Clinical Research Unit, Fonazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Van Coevorden F; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Van Houdt W; The Netherlands Cancer Institute, Amsterdam, The Netherlands., Bonvalot S; Institut Curie, Paris, France., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Skoczylas J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Swallow CJ; Department of Surgery, Mount Sinai Hospital and Princess Margaret Cancer Centre University of Toronto, Toronto, Canada., Gladdy R; Department of Surgery, Mount Sinai Hospital and Princess Margaret Cancer Centre University of Toronto, Toronto, Canada., Strauss DC; Royal Marsden Hospital NHS Foundation Trust, London, UK., Hayes A; Royal Marsden Hospital NHS Foundation Trust, London, UK., Fairweather M; Brigham and Women's Hospital, Dana-Farber Cancer Institute Harvard Medical School, Boston, USA., Raut CP; Brigham and Women's Hospital, Dana-Farber Cancer Institute Harvard Medical School, Boston, USA., Jakob J; Department of Surgery, Sarcoma Unit, University Medical Center Mannheim (UMM) and Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. jens.jakob@umm.de.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Nov 28; Vol. 150 (12), pp. 514. Date of Electronic Publication: 2024 Nov 28.

On the Origin of Abdominal Venous Leiomyosarcomas: The Role of the Sex-Hormone Drainage Pathways.

Autor: Tarique U; Department of Medical Imaging, University of Toronto, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.; These authors contributed equally to this article., Cyr DP; Department of Surgery, University of Toronto, Toronto, ON, Canada.; These authors contributed equally to this article., Morosi C; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Dickson BC; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Greco G; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Swallow CJ; Department of Surgery, University of Toronto, Toronto, ON, Canada., Callegaro D; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Gladdy RA; Department of Surgery, University of Toronto, Toronto, ON, Canada., Khalili K; Department of Medical Imaging, University of Toronto, Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada.

Publikováno v: World journal of oncology [World J Oncol] 2024 Oct; Vol. 15 (5), pp. 758-768. Date of Electronic Publication: 2024 Jul 18.

New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter.

Autor: Callegaro D; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Barretta F; Department of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Raut CP; Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Johnston W; Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada., Strauss DC; Sarcoma Unit, Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, United Kingdom., Honoré C; Department of Surgery, Institut Gustave Roussy, Villejuif, France., Bonvalot S; Department of Surgery, Institut Curie, Paris, France., Fairweather M; Department of Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gladdy RA; Department of Surgical Oncology, Princess Margaret Cancer Centre, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Surgery, University of Toronto, Toronto, ON, Canada., Tirotta F; Sarcoma Unit, Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Department of Sarcoma and General Surgery, Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Tzanis D; Department of Surgery, Institut Curie, Paris, France., Skoczylas J; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Haas RL; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Miceli R; Department of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Swallow CJ; Department of Surgical Oncology, Princess Margaret Cancer Centre, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Surgery, University of Toronto, Toronto, ON, Canada., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Publikováno v: Annals of surgery [Ann Surg] 2024 May 01; Vol. 279 (5), pp. 857-865. Date of Electronic Publication: 2023 Sep 27.

Tumor Budding Assessment in Colorectal Carcinoma: Normalization Revisited.

Autor: Cyr DP; Lunenfeld-Tanenbaum Research Institute.; Institute of Medical Science.; Department of Surgery, Division of General Surgery, University of Toronto.; Department of Surgical Oncology, Princess Margaret Cancer Centre and Sinai Health System., Pun C; Department of Pathology and Laboratory Medicine, Sinai Health System.; Department of Laboratory Medicine Pathobiology, University of Toronto., Shivji S; Department of Pathology and Laboratory Medicine, Sinai Health System., Mitrovic B; Department of Pathology and Laboratory Medicine, Health Sciences North, Sudbury, ON, Canada., Duan K; Department of Laboratory Medicine Pathobiology, University of Toronto.; Laboratory Medicine Program, University Health Network, Toronto., Tomin R; Department of Pathology and Laboratory Medicine, Sinai Health System., Sari A; Department of Pathology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey., Brar A; Department of Surgery, Division of General Surgery, University of Toronto., Zerhouni S; Department of Surgery, Division of General Surgery, University of Toronto.; Department of Surgical Oncology, Princess Margaret Cancer Centre and Sinai Health System., Brar MS; Department of Surgery, Division of General Surgery, University of Toronto., Kennedy ED; Department of Surgery, Division of General Surgery, University of Toronto.; Department of Surgical Oncology, Princess Margaret Cancer Centre and Sinai Health System., Swallow CJ; Lunenfeld-Tanenbaum Research Institute.; Institute of Medical Science.; Department of Surgery, Division of General Surgery, University of Toronto.; Department of Surgical Oncology, Princess Margaret Cancer Centre and Sinai Health System., Kirsch R; Lunenfeld-Tanenbaum Research Institute.; Department of Pathology and Laboratory Medicine, Sinai Health System.; Department of Laboratory Medicine Pathobiology, University of Toronto., Conner JR; Lunenfeld-Tanenbaum Research Institute.; Department of Pathology and Laboratory Medicine, Sinai Health System.; Department of Laboratory Medicine Pathobiology, University of Toronto.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2024 Mar 01; Vol. 48 (3), pp. 251-265. Date of Electronic Publication: 2023 Dec 18.

Combination of clinical, radiomic, and "delta" radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma.

Autor: Krishna S; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada., Sertic A; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada., Liu ZA; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Liu Z; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Darling GE; Division of Thoracic Oncology, Toronto General Hospital, University Health Network, Toronto, ON, Canada., Yeung J; Division of Thoracic Oncology, Toronto General Hospital, University Health Network, Toronto, ON, Canada., Wong R; Division of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada., Chen EX; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kalimuthu S; Division of Pathology, Toronto General Hospital, University Health Network, Toronto, ON, Canada., Allen MJ; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Suzuki C; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Panov E; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Ma LX; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Bach Y; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Jang RW; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Swallow CJ; Department of Surgery, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Brar S; Department of Surgery, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Elimova E; Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Veit-Haibach P; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Aug 14; Vol. 13, pp. 892393. Date of Electronic Publication: 2023 Aug 14 (Print Publication: 2023).